Skip to main content
Heterogeneity of hemoglobin H disease in childhood.
S1P lyase: a novel therapeutic target for ischemia-reperfusion injury of the heart.
S1P lyase regulates DNA damage responses through a novel sphingolipid feedback mechanism.
Chromatin remodelling complex dosage modulates transcription factor function in heart development.
CTCF promotes muscle differentiation by modulating the activity of myogenic regulatory factors.
Stage II palliation of hypoplastic left heart syndrome without cardiopulmonary bypass.
Early systemic-to-pulmonary artery shunt intervention in neonates with congenital heart disease.
The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010?
HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events.
Distinguishing 3 classes of corpus callosal abnormalities in consanguineous families.